Company profile: Sofar Farmaceutici
1.1 - Company Overview
Company description
- Provider of dietary supplements and medical devices, including Sofargen, a silver sulfadiazine topical dressing launched in 1985 and listed by WHO among its 200 essential drugs.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Sofar Farmaceutici
Alpex
HQ: Switzerland
Website
- Description: Provider of research and development and production of orally dispersible tablets (ODT), also known as fast melt, and effervescent tablets. Offers a unique proprietary covering ODT technology, supported by high production capacity and advanced R&D technologies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Alpex company profile →
Explora BioLabs
HQ: United States
Website
- Description: Provider of preclinical, AAALAC-accredited vivarium rental facilities and contract vivarium operation services, delivering turnkey in vivo facilities, management, and related services for biopharmaceutical clients in biotech-dense areas, with vivarium management ensuring maintenance and compliance and CRO options to support early-stage research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Explora BioLabs company profile →
FairJourney Biologics
HQ: Portugal
Website
- Description: Provider of end-to-end antibody discovery and development solutions, leveraging top-tier technologies and seasoned researchers to deliver high-quality, reliable antibodies tailored to partner needs. Services include customized cell line engineering for research and support from discovery to clinical trials; organizer of The Antibody Series on innovations in antibody discovery and development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full FairJourney Biologics company profile →
Catalent
HQ: United States
Website
- Description: Provider of advanced drug delivery technologies and outsourced development, manufacturing, and packaging services for the pharmaceutical, biotechnology, and consumer health industries worldwide. Includes Development & Clinical Services; Oral, Sterile, and Packaging technologies; ProteoSuite Oral; Softgel technologies; inhalation development & analytical; biologics development with GMP analytics; clinical supply services; consumer health products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Catalent company profile →
Pfanstiehl
HQ: United States
Website
- Description: Provider of cGMP-produced high-purity, injectable-grade excipients and bioprocessing solutions, specializing in isolation, purification, custom synthesis, and scale-up of regulated, low endotoxin injectable formulation ingredients, pharmaceutical intermediates, and APIs in gram to multi-ton quantities. Products include TRIS HCl, sodium gluconate, sucrose, trehalose, galactose, and L-arginine.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pfanstiehl company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Sofar Farmaceutici
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Sofar Farmaceutici
2.2 - Growth funds investing in similar companies to Sofar Farmaceutici
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Sofar Farmaceutici
4.2 - Public trading comparable groups for Sofar Farmaceutici
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →